| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 92,445,307 | 131,974,786 | 101,182,511 | | Cost of Revenue | 18,347,246 | 25,585,746 | 20,336,581 | | | Gross Profit | 74,098,061 | 106,389,040 | 80,845,930 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 25,123,673 | 31,515,641 | 25,957,098 | | Non Recurring | 469,430 | (19,148) | 294,427 | | Others | 15,602,560 | 901,415 | 435,699 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 32,902,398 | 73,991,132 | 54,158,706 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 32,902,398 | 73,991,132 | 54,158,706 | | Interest Expense | 40,995,486 | 61,104,729 | 43,431,269 | | Income Before Tax | (8,093,088) | 12,886,402 | 10,727,438 | | Income Tax Expense | (2,600,897) | 3,297,823 | 2,884,856 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,492,191) | 9,588,579 | 7,842,582 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 60,734 | | Other Items |
-
|
-
|
-
| | | | Net Income | (5,492,191) | 9,588,579 | 7,903,316 | | Preferred Stock And Other Adjustments | 85,992 |
-
|
-
| | | Net Income Applicable To Common Shares | ($5,406,200) | $9,588,579 | $7,903,316 |
|
0.29% Nasdaq 
Income Statement
